Although desensitization has not proven to be entirely reliable, one may elect to cautiously continue carboplatin therapy using a
desensitization protocol.5,8,13,14 Participating patients must understand that, although successful in many cases, recurrent reactions may be severe, and death from anaphylaxis has been reported in one patient undergoing a trial of desensitization.